AstraZeneca, J&J Resuming Phase III COVID-19 Vaccine Trials

AstraZeneca and Johnson & Johnson said they will resume Phase III trials of their COVID-19 vaccine candidates, at the recommendation of safety boards overseeing the studies that found no evidence the vaccines caused the patient illnesses that touched off pauses in recruitment.

Read the full article here

Related Articles